Key Takeaways
- • Glenview Capital, the $6.37 billion hedge fund led by Larry Robbins, made Meta Platforms, Advanced Micro Devices and Humana its three biggest additions in Q3, according to its 13F filed Nov. 16.
- • Meta received the largest dollar addition at 495,268 shares worth $359 million at Sept. 30, a 39% increase from the prior quarter, and the stock trades at about 18x forward earnings versus a five-year average of 21x.
- • AMD stake rose 31% to 391,267 shares worth $239 million, while Humana stake more than doubled (up 115%) to 545,385 shares worth $208 million at Sept. 30.
- • Analysts' average price targets sit 42% above Meta's last close and 34% above both AMD's and Humana's, per TIKR's analyst data.
- • Meta's capex guidance of $135 billion to $145 billion for 2026 exceeds its operating cash flow, and consensus projects free cash flow of negative $48.0 billion in 2027.
Summary
Meta was the largest of the three additions, with 495,268 shares valued at $359 million, making it the fund's fourth-largest position at 6.4% of its 13F stocks. Glenview also held Meta call options with a notional value of $36 million. Dan Loeb's Third Point made Meta its largest US holding in the same quarter. The primary concern is capital spending: Meta's third-quarter capex of $34.9 billion exceeded its $32.8 billion in operating cash flow, and the company guides 2026 capex to $135 billion to $145 billion. Meta trades at about 18x forward earnings, below its five-year average of 21x, and its average analyst target of $848 sits 42% above the last close.
AMD's stake grew 31% to 391,267 shares worth $239 million, making it the fund's eighth-largest position at 4.3%. AMD has guided to a fourth-quarter gross margin of about 55%, at the bottom of its 55% to 58% long-term range, as its Helios racks ramp. On Nov. 16, the Commerce Department's Bureau of Industry and Security issued an interim final rule requiring licenses for advanced US AI chips shipped to Indonesia, Malaysia, Singapore, Thailand and Brazil, a category that covers AMD's Instinct GPUs. Consensus normalized EPS for 2028 has risen to $25.52 from $22.80 earlier in the month. AMD trades at about 32x forward earnings, below its five-year average of 35x, with an average target of $658.
Humana's stake more than doubled by 115% to 545,385 shares worth $208 million, making it the fund's 10th-largest position at 3.7%. Glenview also held Humana put options with a notional value of $6 million. Humana raised its 2026 adjusted EPS guidance to at least $9.50 from at least $9.00 on Nov. 6. The stock reached a 52-week high of $461.25 on Nov. 16, but a federal proposal on Nov. 18 could allow regulators to recover Medicare Advantage overpayments dating to 2018, which bears on the margin plan. The stock now sits 18% below that high. Humana trades at about 22x forward earnings, with an average target of $509.
TIKR's analysis favors Meta on valuation and upside to consensus targets, while noting the free cash flow risk and a $25 billion New Mexico court penalty ordered on Oct. 21, which Meta plans to appeal. The key near-term test is Meta's fourth-quarter report in late January, when it will outline its 2027 budget and capex plan. The fund's next 13F, due by mid-February, will show whether Glenview continued adding to these positions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.